Dai Shi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Positron Emission Tomography

Top Venues

Molecular pharmaceutics

Contrast media & molecular imaging

Molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Kaibin Lin, Dai Shi, Ai Wang, Junbo Ge, Dengfeng Cheng, Yan Yan
Noninvasive Monitoring of Early Cardiac Fibrosis in Diabetic Mice by [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT Imaging. ACS omega 9 (15) (2024)
Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4. Molecular pharmaceutics 21 (5) (2024)
Kaibin Lin, Dai Shi, Ai Wang, Junbo Ge, Dengfeng Cheng, Yan Yan
Noninvasive Monitoring of Early Cardiac Fibrosis in Diabetic Mice by [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT Imaging. ACS omega 9 (15) (2024)
Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4. Molecular pharmaceutics 21 (5) (2024)
Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4. Molecular pharmaceutics (2024)
Kaibin Lin, Dai Shi, Ai Wang, Junbo Ge, Dengfeng Cheng, Yan Yan
Noninvasive Monitoring of Early Cardiac Fibrosis in Diabetic Mice by [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT Imaging. ACS omega 9 (15) (2024)
Dai Shi, Wenhui Fu, Hui Tan, Qingyu Lin, Hongcheng Shi, Dengfeng Cheng
Preclinical Evaluation of 99m Tc-MAG 3 -5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99m Tc-MAG 3 -5-F(ab') 2 . Molecular pharmaceutics 21 (1) (2023)
Dai Shi, Wenhui Fu, Hui Tan, Qingyu Lin, Hongcheng Shi, Dengfeng Cheng
Preclinical Evaluation of 99m Tc-MAG 3 -5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99m Tc-MAG 3 -5-F(ab') 2 . Molecular pharmaceutics 21 (1) (2023)
Zhan Si, Yuan Cheng, Zhan Xu, Dai Shi, Hongcheng Shi, Dengfeng Cheng
Exploration of 68 Ga-DOTA-MAL as a Versatile Vehicle for Facile Labeling of a Variety of Thiol-Containing Bioactive Molecules. ACS omega 8 (5) (2023)
Zhan Si, Yuan Cheng, Zhan Xu, Dai Shi, Hongcheng Shi, Dengfeng Cheng
Exploration of 68 Ga-DOTA-MAL as a Versatile Vehicle for Facile Labeling of a Variety of Thiol-Containing Bioactive Molecules. ACS omega 8 (5) (2023)
Dai Shi, Zhan Xu, Yuan Cheng, Qingyu Lin, Zhan Si, Wenhui Fu, Tingting Yang, Hongcheng Shi, Dengfeng Cheng
124 I-Labeled Immuno-PET Targeting hTREM2 for the Diagnosis of Gastric Carcinoma. Molecular pharmaceutics (2023)
Dai Shi, Wenhui Fu, Hui Tan, Qingyu Lin, Hongcheng Shi, Dengfeng Cheng
Preclinical Evaluation of 99m Tc-MAG 3 -5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99m Tc-MAG 3 -5-F(ab') 2 . Molecular pharmaceutics (2023)
Zhequan Fu, Qingyu Lin, Zhan Xu, Wenhui Fu, Dai Shi, Yuan Cheng, Tingting Yang, Guobing Liu, Hongcheng Shi, Dengfeng Cheng
Longitudinal Positron Emission Tomography Imaging with P2X7 Receptor-Specific Radioligand 18 F-FTTM in a Kainic Acid Rat Model of Temporal Lobe Epilepsy. ACS chemical neuroscience 13 (23) (2022)
Dai Shi, Zhan Si, Zhan Xu, Yuan Cheng, Qingyu Lin, Zhequan Fu, Wenhui Fu, Tingting Yang, Hongcheng Shi, Dengfeng Cheng
Synthesis and Evaluation of 68 Ga-NOTA-COG1410 Targeting to TREM2 of TAMs as a Specific PET Probe for Digestive Tumor Diagnosis. Analytical chemistry 94 (9) (2022)
Dai Shi, Yiqiu Zhang, Zhan Xu, Zhan Si, Yuan Cheng, Dengfeng Cheng, Guobing Liu
Noninvasive Evaluation of EGFR Expression of Digestive Tumors Using 99m Tc-MAG 3 -Cet-F(ab') 2 -Based SPECT/CT Imaging. Molecular imaging 2022 (2022)
Yuan Cheng, Dai Shi, Zhan Xu, Zhihui Gao, Zhan Si, Yanzhao Zhao, Renjie Ye, Zhequan Fu, Wenhui Fu, Tingting Yang, Yan Xiu, Qingyu Lin, Dengfeng Cheng
124 I-Labeled Monoclonal Antibody and Fragment for the Noninvasive Evaluation of Tumor PD-L1 Expression In Vivo . Molecular pharmaceutics 19 (10) (2022)
Yu Ji, Chunchun Shao, Yong Cui, Dai Shi, Na Su, Yaru Wang, Jing Song Zheng
Sacral Insufficiency Fracture after Radiotherapy for Cervical Cancer: Appearance and Dynamic Changes on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Contrast media & molecular imaging 2021 (2021)
Yingying Zhang, Qingyu Lin, Tingting Wang, Dai Shi, Zhequan Fu, Zhan Si, Zhan Xu, Yuan Cheng, Hongcheng Shi, Dengfeng Cheng
Targeting Infiltrating Myeloid Cells in Gastric Cancer Using a Pretargeted Imaging Strategy Based on Bio-Orthogonal Diels-Alder Click Chemistry and Comparison with 89Zr-Labeled Anti-CD11b Positron Emission Tomography Imaging. Molecular pharmaceutics (2021)
Dai Shi, Weiwei Liu, Shanshan Zhao, Chao Zhang, Ting Liang, Guihua Hou
TLR5 is a new reporter for triple-negative breast cancer indicated by radioimmunoimaging and fluorescent staining. Journal of cellular and molecular medicine 23 (12) (2019)
Dai Shi, Shanshan Zhao, Wen Jiang, Chao Zhang, Ting Liang, Guihua Hou
TLR5: A prognostic and monitoring indicator for triple-negative breast cancer. Cell death & disease 10 (12) (2019)